Zepbound dosage chart
Everyone starts in the same place: 2.5 mg once weekly. From there, the FDA label lays out a ladder — steps of 2.5 mg, each held for at least 4 weeks, topping out at 15 mg.
| Dose | When | Notes |
|---|---|---|
| 2.5 mg | Weeks 1–4 | Starting dose — helps your body adjust; not for long-term use |
| 5 mg | Weeks 5–8 | First maintenance option |
| 7.5–10 mg | From week 9 | Stepped up in 2.5 mg increments, at least 4 weeks apart |
| 12.5–15 mg | Later months | 15 mg is the maximum; maintenance doses are 5, 10, or 15 mg |
Reading the ladder: the first four weeks at 2.5 mg are an adjustment period, not a treatment target. Weeks 5–8 move to 5 mg — the first dose the label recognizes for long-term maintenance. From week 9 onward, increases continue in 2.5 mg increments as needed and tolerated, always at least 4 weeks apart, until you land at a maintenance dose of 5, 10, or 15 mg.
Two things the chart doesn’t say out loud. First, “at least 4 weeks” is a minimum, not a schedule — plenty of people spend 8 or 12 weeks on a step, and the label explicitly allows delaying escalation when side effects need more time to settle. Second, the ladder isn’t a race to 15 mg. The top dose is a ceiling for the people who need it, not a finish line everyone is supposed to reach. Your prescriber decides the pace; this page just describes the map.
What is the starting dose of Zepbound?
2.5 mg once weekly, for four weeks — and per the label, it’s for treatment initiation only, not long-term use. Think of it as the clutch, not the engine: its job is to let your digestive system adjust to a slower pace before the doses that do the heavy lifting arrive.
Set expectations accordingly. At 2.5 mg, most people notice appetite quieting — food noise drops, portions shrink on their own — but the scale usually moves modestly. That’s the design, not a failure. The trial results everyone quotes came from months at maintenance doses, not from week 3 of the ramp. Judging Zepbound at 2.5 mg is like judging a marathon at the first mile marker.
What the first month is actually for: learning your injection routine, watching how your stomach responds, and building the eating habits (smaller meals, more protein, more water) that make the rest of the ladder smoother. People who treat month one as practice tend to have an easier climb than people who treat it as a verdict.
Maintenance and maximum doses
The label recognizes three maintenance doses — 5 mg, 10 mg, or 15 mg once weekly — and 15 mg is the maximum. The in-between strengths (7.5 and 12.5 mg) are stepping stones on the way up, though some people park there when a step suits them (⚠ verify label framing of in-between doses as maintenance).
Higher isn’t automatically better. In the 72-week SURMOUNT-1 trial, average body-weight loss by dose was 15.0% on 5 mg, 19.5% on 10 mg, and 20.9% on 15 mg. Notice the shape of that curve: the jump from 5 to 15 mg — a tripling of the dose — bought about six additional percentage points, while GI side effects climb with dose. For a lot of people, 5 or 10 mg is the spot where results and tolerability meet, and the label treats staying there as a perfectly valid endpoint.
The honest framing: the maximum dose exists for the people who need it and tolerate it. It is not a score to max out.
What if I miss a dose of Zepbound?
The label’s rule is a 4-day window (⚠ verify — 96 hours per the label): if you’re within 4 days of your usual injection time, take the missed dose and carry on with your normal schedule. If more than 4 days have passed, skip it entirely and take the next dose on your regular day.
The one hard rule: never double up. Two doses to “catch up” just means one oversized week of side effects with no added benefit.
If you want to permanently change your injection day, the label describes keeping at least 3 days (72 hours) between doses when you shift (⚠ verify the 3-day wording). So moving from Sunday to Wednesday is fine in a single week; moving from Sunday to Monday means waiting for the following week’s Monday rather than injecting back-to-back.
Occasional missed weeks won’t erase your progress — appetite effects taper rather than vanish. But repeated gaps are different: after an extended break, prescribers often restart the titration at a lower dose rather than resuming where you left off, because your gut loses its adjustment along with the drug. That call belongs to your prescriber, not the leftover pens in your fridge.
Moving up, staying, or stepping down
The ladder runs in three directions, and all three are legitimate:
- Moving up makes sense when a dose is well-tolerated and progress has genuinely stalled — for at least 4 weeks, per the label, and in practice often longer. One flat week is noise; a flat month at a stable dose is information.
- Staying put is underrated. Plateaus happen on every dose eventually — that’s biology finding its new equilibrium, not the drug quitting. If your current dose is holding results you’re happy with and your side effects are minimal, staying is a strategy, not a stall.
- Stepping down is allowed and ordinary. If a new dose brings side effects that won’t fade, prescribers routinely drop back to the last dose that worked and re-approach later — or never, if the lower dose does the job.
The pattern worth internalizing: side effects are dose-shaped and time-shaped. They spike in the first weeks after a step up and fade as your body adjusts, which is exactly why the label builds in 4-week minimums. Slower is a feature.
Vials vs pens: dose formats
The same milligrams come in three containers, and the container affects both routine and price:
- Single-dose pen — the default. A push-button auto-injector, one fixed dose per pen, available across the strength range. No drawing up, no dose-setting, nothing to get wrong.
- KwikPen — a multi-dose pen covering four weekly doses, sold through Lilly’s self-pay channel (⚠ verify current strengths and availability).
- Single-dose vials — the budget format, sold through LillyDirect’s self-pay program. You draw each dose with a needle and syringe, which is the trade that makes it cheaper. Historically the vials have covered the lower strengths rather than the full ladder (⚠ verify which doses are offered).
The dose itself is identical across formats — 5 mg is 5 mg — so the choice comes down to comfort with syringes, what your coverage pays for, and what each format costs out of pocket. That last one varies more than you’d think: on the self-pay route, your dose tier sets your monthly price. The Zepbound cost guide has the full breakdown.
Zepbound: the complete guide What it is, how well it works, what it costs, and how to get it